2023
DOI: 10.1136/bmjopen-2023-073917
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound-guided anterior quadratus lumborum block at the L2 level for postsurgical analgesia in patients undergoing laparoscopic gynaecological surgery: a single-centre, randomised, double-blinded trial at a university-affiliated hospital in China

Lvdan Huang,
Yaoyao Cai,
Lili Yang
et al.

Abstract: ObjectiveThis study aimed to investigate the analgesic effect of an ultrasound-guided anterior quadratus lumborum block (QLB) at the L2 level on postoperative pain after laparoscopic gynaecological surgery.DesignProspective single-centre randomised double-blind trial.SettingUniversity-affiliated hospital.ParticipantsSixty patients aged between 18 and 65 years scheduled for laparoscopic gynaecological surgery.InterventionsBefore surgery, bilateral anterior QLB was performed with 20 mL of 0.375% ropivacaine inje… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…In group Q, after the target site was determined, 20 ml of 0.50% lidocaine (Hebei Tiancheng Pharmaceutical Co., Ltd; Approval number: H13022313; Specification: 5 ml:100 mg) and 0.20% ropivacaine (Shijiazhuang No.4 Pharmaceutical Co. Ltd.; Approval number: H20203107; Specification:10 ml:100 mg) diluted in NS was injected into each side 11 . In group C, 20 ml of NS was injected into each side, and the dermatomes of the sensory block at the 15th minute were evaluated using a pinprick for all subjects 12 , 13 .…”
Section: Methodsmentioning
confidence: 99%
“…In group Q, after the target site was determined, 20 ml of 0.50% lidocaine (Hebei Tiancheng Pharmaceutical Co., Ltd; Approval number: H13022313; Specification: 5 ml:100 mg) and 0.20% ropivacaine (Shijiazhuang No.4 Pharmaceutical Co. Ltd.; Approval number: H20203107; Specification:10 ml:100 mg) diluted in NS was injected into each side 11 . In group C, 20 ml of NS was injected into each side, and the dermatomes of the sensory block at the 15th minute were evaluated using a pinprick for all subjects 12 , 13 .…”
Section: Methodsmentioning
confidence: 99%